Gene Query: ARID2

Dataset Description Geneva Score
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 48.44
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 40.52
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 30.32
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 30.18
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 24.64
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 24.64
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 24.15
Genes significantly down or Up-regulated upon RNF219 knockdown 22.76
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 22.7
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 22.59
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 21.16
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 21.12
Transcriptome analysis in Neobractatin treated cells 18.8
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 18.53
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 18.52
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 18.14
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 18.11
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 17.81
Transcription elongation regulates genome 3D structure 17.6
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 17.38
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 17.28
Lysine benzoylation is a novel histone mark 16.65
Lysine benzoylation is a novel histone mark [RNA-seq] 16.65
Targeting MTHFD2 in Acute Myeloid Leukemia 16.33
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 16.17
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 15.79
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 15.71
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 15.52
RNA sequencing of mechanically strained NHEKs and control NHEKs 15.38
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 15.38
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 15.33
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 15.32
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 15.32
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 15.22
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 15.12
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 14.74
Gene expressions of H9s in different culture systems 14.48
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 14.0
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 13.61
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 13.43
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 13.23
LNCaP treated with iBET 12.92
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 12.8
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 12.79
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 12.52
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 12.52
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 12.21
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 12.21
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 12.05
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 12.05
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 12.0
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 11.95
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 11.94
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 11.93
Recovery and analysis of nascent RNA 11.93
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 11.86
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 11.73
Human cell line and subcutaneous tumor 11.64
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 11.52
Gene expression changes caused by KRAS in MCF-10A 11.45
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 11.43
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 11.41
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 11.4
Impact of dieldrin on transcription in Jurkat T cells 11.37
Transcriptomic analyssis following EHMT1/2 inhibition 11.26
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 11.25
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 11.18
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 11.09
Knockdown of ADNP in HCT116 colon cancer cells 10.52
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 10.52
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 10.44
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 10.41
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 10.37
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 10.36
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 10.23
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 10.23
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 10.06
RNA-seq analyses of human prostate cancer cells 9.94
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 9.94
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 9.77
Zika infected neural stem cells 9.75
Transcriptome analysis of Zika infected neural stem cells 9.75
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 9.75
RNA-seq analysis of AML cells in response to ASLAN003 9.64
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 9.57
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 9.57
High-throughput sequencing of PROMPT-enriched samples. 9.54
RNA-seq of YB5 cells treated with Proscillaridin A 9.49
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 9.47
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 9.41
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 9.35
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 9.35
LncRNA-GAS5 negative regulation of YAP-target genes expression 9.34
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 9.22
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 9.2
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 9.16
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 9.14
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 9.14
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 9.12
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 9.05
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 9.01
AMPK signaling for naïve pluripotency [Hs] 8.92
AMPK signaling for naïve pluripotency 8.92
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 8.9
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 8.84
Differentially expressed genes post knock down of lincDUSP26 8.73
METTL3 promotes translation in human cancer cells 8.71
Pharmacologic inhibition of STAT5 in AML 8.6
Effect of drugs on transcriptomic profiles 8.57
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 8.49
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 8.47
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 8.45
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 8.45
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 8.42
Role for citron kinase in prostate cancer growth 8.38
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 8.37
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 8.34
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 8.3
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 8.23
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 8.23
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 8.23
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 8.22
DJ-1 is dispensable for human stem cell homeostasis 8.18
LINE-2 transposable elements are a source of functional human microRNAs and target sites 8.17
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 8.15
Cleavage Factor Im as a key regulator of 3’ UTR length 8.09
SRSF2 mutations impair hematopoiesis and alter exon recognition 8.08
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 8.07
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 8.05
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 8.04
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 8.04
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 7.99
U1 snRNP telescripting regulates size-function stratified human genome 7.98
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 7.97
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 7.91
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 7.91
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.88
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 7.85
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 7.79
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 7.74
The evolution of N6-methyladenosine in primates 7.74
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 7.67
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 7.67
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 7.67
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 7.65
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 7.62
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 7.6
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 7.6
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 7.59
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 7.59
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 7.55
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 7.55
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 7.54
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 7.51
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.49
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 7.41
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.4
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 7.37
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 7.33
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 7.33
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 7.31
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 7.3
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 7.29
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 7.29
A prostate cancer chromatin interaction map 7.28
RNA-sequencing in irradiated and normal A549 cells. 7.24
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 7.2
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 7.15
FBXW7 modulates stress response by post-translational modification of HSF1 7.15
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 7.11
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 7.04
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 7.03
RNAseq Study in CC-671 Treated Cal-51 Cells 6.99
Survival of pancreatic cancer cells lacking KRAS function 6.97
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 6.94
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 6.94
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.93
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 6.93
Functional role of SLIT2 and ROBO1 in trophoblasts 6.89
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 6.84
Global Mapping of Human RNA-RNA Interactions 6.83
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 6.82
Epigenetic reprogramming of melanoma cells by vitamin C treatment 6.82
Transcriptomic profiling of human peripheral blood-derived mast cells 6.82
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 6.82
RNA-Sequencing of HepG2 cells treated with TGFBeta 6.78
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 6.68
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.61
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 6.6
SLAM-seq for K562 endogenous mRNA decay 6.59
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 6.56
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 6.56
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 6.54
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 6.54
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 6.53
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 6.53
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 6.52
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 6.5
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 6.48
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 6.48
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 6.46
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 6.42
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 6.39
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 6.26
Expression and functions of long noncoding RNAs during human T helper cell differentiation 6.25
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 6.24
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 6.22
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 6.19
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 6.18
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 6.17
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 6.13
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 6.12
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 6.1
Effect of PBK knockdown on C4-2 cell transcriptome 6.06
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 6.04
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 6.02
Interaction between mitoNEET and NAF-1 in cancer cells 6.02
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 5.97
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 5.96
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 5.95
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 5.91
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 5.86
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 5.86
DRB/GRO-Seq -/+ UV 5.85
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 5.77
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 5.74
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.74
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 5.7
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 5.67
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 5.64
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 5.61
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 5.61
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 5.59
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 5.59
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 5.53
Direct Isolation and Characterization of Human Nephron Progenitors. 5.52
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 5.51
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.51
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 5.45
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 5.41
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 5.41
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 5.39
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 5.38
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.36
Targeting EZH2 in MYCN-amplified Neuroblastoma 5.34
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 5.34
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 5.3
RNA-sequencing 5.29
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 5.27
BET bromodomain inhibition 5.27
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 5.25
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 5.25
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.21
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 5.17
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 5.17
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.16
Global transcriptome analysis of HAP1 cells 5.14
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 5.09
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 5.08
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 5.04
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 4.99
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 4.99
RNA-seq of RKO cells with cTAZ KO or putback 4.99
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 4.97
Paxillin regulates genomic networks in prostate cancer [C4-2] 4.92
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 4.89
4sUDRB-seq: measuring transcription elongation and initiation genomewide 4.89
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 4.88
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.86
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 4.83
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 4.82
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 4.82
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 4.8
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 4.8
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 4.79
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 4.79
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 4.78
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.77
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 4.72
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 4.7
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 4.67
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 4.67
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 4.57
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 4.55
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.5
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.44
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 4.42
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 4.42
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 4.4
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 4.38
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 4.37
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.23
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 4.17
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 4.17
Single-Cell Genotyping of Transcriptomes 4.16
RNA-seq of Single-Cell Genotyping of Transcriptomes 4.16
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 4.13
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 4.13
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 4.12
Transcriptome analysis of CNS leukemia 4.12
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 4.12
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.07
Triple vectors expand AAV transfer capacity in the retina 4.04
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 4.04
Searching for target genes of miR-508/509/506/514 in HCT116 cells 3.96
EWS-Fli and LNC regulated genes in comparison to GFP samples 3.94
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 3.93
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.88
Co-regulation of splicing by Rbfox1 and hnRNP M 3.87
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.87
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 3.84
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 3.78
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 3.77
Gene expression analysis in response to hypoxic pathway inhibition 3.75
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.73
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 3.72
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 3.67
Splicing and epigenetic factors jointly regulate epidermal differentiation 3.66
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.65
The transcriptome effect of overexpressing EZH2 in MCF7 3.62
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 3.61
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.59
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.58
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.58
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 3.56
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 3.55
The pioneer factor CEBPA modulates vitamin D signaling 3.55
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 3.51
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 3.51
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 3.51
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.5
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.5
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 3.47
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.44
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 3.43
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 3.43
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 3.35
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 3.32
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 3.27
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 3.24
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 3.24
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.24
UV_24h_GRO-Seq 3.23
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 3.21
RNA-Seq with and without RNase treatment in PCa cell lines 3.2
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.18
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 3.18
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.16
Capturing the Interactome of Newly Transcribed RNA 3.16
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.13
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.11
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.11
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 3.11
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 3.07
Identification of renal resident macrophages across species [C1] 3.06
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.05
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.02
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.98
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.93
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 2.91
Functional significance of the HIV-1 Tat signature amino acid residues 2.86
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 2.81
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.8
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.78
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.78
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 2.74
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.59
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.57
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.57
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 2.5
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.48
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 2.45
High-resolution comparative analysis of great ape genomes 2.43
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.41
The contribution of Alu exons to the human proteome 2.38
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 2.37
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.35
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.32
The cohesin release factor WAPL restricts chromatin loop extension. 2.32
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 2.22
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 2.2
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 2.17
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.15
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 2.08
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.03
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 2.0
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.98
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.97
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.95
Targeted enhancer activation by a subunit of the integrator complex 1.93
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.88
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.87
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.83
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 1.81
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.8
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.79
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.79
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.76
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 1.76
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.72
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.68
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.68
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 1.62
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.6
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.6
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.57
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.52
RNA-seq data 1.5
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.5
Human Treg IFNg/IL-10 subpopulations 1.47
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 1.46
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 1.44
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 1.44
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.43
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.42
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.4
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 1.36
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 1.36
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.34
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 1.33
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.33
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 1.32
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.28
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.23
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.23
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 1.23
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 1.23
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 1.23
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 1.19
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.18
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.18
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.17
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.11
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.11
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.07
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.05
RNA-seq analysis of control and Myc-induced U2OS cells 1.04
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.03
Gene expression analysis of human hepatocellular cancers 0.99
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 0.99
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.99
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.99
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.94
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.94
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.92
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.92
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.89
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.89
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.88
Aging-associated patterns in the expression of human endogenous retroviruses 0.86
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.82
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.79
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.73
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.71
Interphase condensins regulate ligand-depedent enhancer activation 0.65
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.65
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.63
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.6
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 0.58
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.54
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.53
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.53
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.53
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.49
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.44
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.44
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.44
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.38
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.38
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.37
NHLRC1 re-expression in cancer cells 0.35
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.35
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.34
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.32
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.32
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.3
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.3
Transcriptomes in healthy and CHB fetal hearts 0.23
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.23
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.23
m6A-dependent regulation of messenger RNA stability 0.22
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.22
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.21
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.21
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.21
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.2
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.15
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.14
Transcriptome-wide modulation of splicing by the exon junction complex 0.11
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.1
RNA-seq of primary patient AML samples 0.05
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.04
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.03
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.03
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.03
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.02
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.01
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation